SB-743921 In Patients With Solid Tumors

Clinical trial NCT00136513 · COMPLETED

Trial details

NCT number: NCT00136513
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Cancer

Start date: 2004-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.